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Endoglin protein (also known as CD105) is a co-receptor for members of 
the transforming growth factor-β (TGFβ) superfamily of ligands, and regulates 
angiogenesis. Patients carrying mutations in the endoglin gene develop the 
inherited vascular dysplasia, Hereditary Haemorrhagic Telangiectasia (HHT). 
In light of the growing clinical interest in endoglin function in cardiovascular 
disease, we aimed to determine its role by depleting endoglin in a mouse 
model during adult life and assess effects on cardiac function. Endoglin was 
depleted in adult Rosa26-Cre-ERT2;Engfl/fl mice using tamoxifen treatment 
to generate “ubiquitous” endoglin knockout (Eng-iKOu) mice and cardiac 
magnetic resonance imaging (MRI) was used to evaluate cardiac function at 
1, 3, 5 and 12 weeks after endoglin knockdown. Loss of endoglin leads to an 
enlarged heart and cardiomyocyte hypertrophy within 5 weeks and left ven-
tricular volumes continued to enlarge substantially over subsequent weeks. 
However, LV ejection fraction was not significantly altered in Eng-iKOu mice 
compared with controls suggesting that cardiac function was not impaired. To 
address whether the cardiac remodelling observed in Eng-iKOu mice was due 
to loss of endoglin in endothelial cells we used a transgenic Cre line 
(Cdh5Cre-ERT2) to generate endothelial specific depletion of endoglin (Eng-
iKOe). These mice showed a similar increase in heart mass and ventricular 
volumes to the Eng-iKOu mice. To investigate if vasomotor defects are 
contributing to the major cardiac remodelling, we analysed vasomotor func-
tion in the aortas of Eng-iKOe mice. We found an increased contraction 
response of the aorta to phenylephrine in Eng-iKOe mice compared to 
controls, suggesting that endoglin is important in controlling the aortic 
contractile response. These results describe a novel phenotype and highlight 
the importance of endothelial endoglin in the maintenance of cardiac structure 
and function.
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Background: Postinfarction remodeling is accompanied and influenced by 
perturbations in MAPK signaling. The Growth arrest and DNA-damage-
inducible 45 (Gadd45) proteins are small acidic proteins involved in DNA 
repair and modulation of MAPK activities. Despite its relationship with p38 
MAPK, little is known about the role of Gadd45 in the heart. Our aim is to 
explore the potential contribution of Gadd45 gamma (γ) on heart failure devel-
opment after myocardial infarction (MI).
Methods and results: MI was induced in wild-type (WT) versus Gadd45 
γ (KO) mice by left anterior descending coronary artery ligation. Pre-MI, WT, 
and KO hearts had comparable chamber dimensions and ventricular function, 
but as early as 1 week post-MI, KO mice had significantly better cardiac func-
tion than WT mice. The left ventricular dilatation, dysfunction and fibrosis 
remained better in the KO mice throughout the study (4 weeks). We examined 
the infarct size following a 24-hour MI and found it to be decreased in the KO 
mice. In addition, necroptosis activity pathway (RIP1; caspase 8) was reduced 
in the KO mice. To mimic the Gadd45 γ overexpression observed during MI, 
we injected 3 10^11 of cTNT-Gadd45 γ AAV9 particles i.v. and studied the 
cardiac function. Four weeks after the cTNT-Gadd45 γ AAV9 injection, we 
observed a decrease in the cardiac function compared to the GFP-AAV9 
injected control mice. A remodeling process is engaging with more fibrosis. 
Gadd45 γ overexpression activated the necroptosis pathway through p38 
MAPK.
Conclusion: Gadd45 γ promotes ischemic injury, accentuates post-MI 
remodeling and left ventricular dysfunction, and increases the progression to 
heart failure. The lost of gadd45 γ confers resistance to ischemic injury, at 
least in part, via limiting necroptosis pathway through a p38 MAPK dependant 
mechanism. This work, demonstrate the importance of Gadd45 γ/p38 MAPK 
complex in the development of heart failure, particularly in the balance of the 
cell death process.
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Chronic activation of β-adrenergic (β-AR) pathway causes excessive 
accumulation of cAMP in cardiomyocytes and participates in pathological car-
diac remodeling leading to heart failure (HF). Cyclic nucleotide phosphodies-
terases (PDEs) are responsible for the degradation of cAMP and cGMP in 
subcellular compartments. Among the different PDE families, PDE2 is unique 
in being activated ~5-fold by cGMP, thus mediating a negative cross talk 
between cGMP and cAMP signaling. Recently, we found that PDE2A activity 
is increased in human HF and this may represent a protective mechanism lim-
iting β-AR cardiotoxicity in chronic HF. Our therapeutic strategy is to target 
PDE2 with specific activators to treat HF at the early stages. A PDE2 activity 
assay has been developed, first using a purified PDE2 from bovine adrenal 
glands, then using a commercial recombinant protein (full-length human 
PDE2A). We miniaturized a bioluminescent activity assay in 384 well plates, 
which was validated for High-Throughput Screening (HTS) with an excellent 
Z-factor (>0.7) on the Ciblot HTS platform. Moreover, an in silico screening 
based on the binding of molecules on the GAF-B domain (regulatory domain) 
of PDE2 has been performed on a large library of molecules. As a counter 
screen, a PDE4 assay has been employed to eliminate nonspecific modulators. 
Ranking of hits is based on activation efficacy in comparison to 5 μM cGMP, 
EC50, Emax and cytotoxicity following chemical resynthesis in a SAR (Struc-
ture Activity Relationship) strategy. Several complementary assays are cur-
rently under development to confirm the effect of the activators in a Hit to 
Lead process (cellular assays, cAMP ELISA, co-cristallisation, Biacore). This 
challenging project is supported by LabEx LERMIT within its new cardio-
vascular target program
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